Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Lead Generation Team in Heidelberg, Germany, we are looking for a fulltime
Reference No.: R2217
For any queries, please contact Susanne Hering (Tel: +49 6221 6743 675, e-mail: email@example.com).